Tetra Bio Pharma Sees Drug Approved By Health Canada

Tetra Bio Pharma (TSXV: TBP) is currently seeing upward price momentum on the discovery that one of its products appears to have been approved by Health Canada. The online Health Canada products database has listed one of the company’s products as “approved,” with the status change date being listed as January 15, 2020.

The product that has been approved for over the counter, or OTC sales is known as Terpacan Back & Muscle Pain, and is one of the first products to be approved by Health Canada that contains known cannabinoids. The product is a topical targeted towards pain relief, and has been assigned the DIN, or drug identification number, of 02495708.

The company has yet to release an official news release on the product approval.

Tetra Bio Pharma last traded at $0.61, up 45% on the leak of the news.


Information for this briefing was found via Sedar, Health Canada and Tetra Bio-Pharma. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Endeavour Mining Q1 Earnings: Cash Flow Is King

G Mining Oko West Feasibility: Move Fast, Break.. Nothing?

New Gold Q1 Earnings: What’s Behind The Market’s Surprising Reaction?

Recommended

First Majestic Posts Record Cash Flows In Q1 As Production Costs Fall

Brazil Potash Secures Funding In Support Of US$2.5 Billion Autozales Project

Related News

Tetra Bio Pharma Strengthens Product Pipeline Via Co-Development Agreement

Tetra Bio Pharma (TSXV: TBP) has strengthened its product pipeline as of this morning, providing...

Thursday, February 27, 2020, 08:53:49 AM

Tetra Bio-Pharma Releases Update Regarding its Veterinary Clinical Study

Tetra Bio-Pharma Inc (TSXV: TBP) has released an update regarding its clinical study for the...

Wednesday, January 29, 2020, 08:55:32 AM

Tetra Bio Pharma Sees Product Approved For FDA Fast Track Designation Request

Tetra Bio-Pharma (TSXV: TBP) has received a much anticipated response from the US Food and...

Monday, February 3, 2020, 08:47:08 AM

Tetra Bio Pharma Announces Commercialization Strategy

Tetra Bio Pharma (TSXV: TBP) released information on its commercialization effort this morning related to...

Monday, January 20, 2020, 08:28:34 AM

Tetra Bio-Pharma Signs Manufacturing Agreement with Vitiprints

Tetra Bio-Pharma Inc. (TSXV: TBP) has entered into a manufacturing agreement with Vitiprints LLC, which...

Thursday, February 13, 2020, 01:46:29 PM